Market Cap 137.43M
Revenue (ttm) 27.86M
Net Income (ttm) -14.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -51.08%
Debt to Equity Ratio 0.00
Volume 143,400
Avg Vol 367,582
Day's Range N/A - N/A
Shares Out 89.24M
Stochastic %K 36%
Beta 2.82
Analysts Strong Sell
Price Target $6.25

Company Profile

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of P...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 765 8585
Fax: 972 3 765 8555
Website: cgen.com
Address:
Azrieli Center, Building D 26 Harokmim Street, Holon, Israel
mary46
mary46 Dec. 27 at 4:25 PM
$CGEN 3s feb
0 · Reply
BiPartisanB
BiPartisanB Dec. 25 at 1:38 PM
$CGEN Capital stewardship is becoming the defining attribute for how this story is priced. Execution reliability across quarters will determine whether confidence can compound. Credibility will build only through repeated confirmation across multiple cycles. Future re‑rating depends on tightening the gap between narrative and reality.
0 · Reply
John_McClane911
John_McClane911 Dec. 24 at 9:40 PM
$CGEN https://www.youtube.com/watch?v=t9WWj19YejM&list=RDt9WWj19YejM&start_radio=1
0 · Reply
John_McClane911
John_McClane911 Dec. 24 at 9:34 PM
$CGEN Chanukka Sameach
0 · Reply
John_McClane911
John_McClane911 Dec. 23 at 6:53 AM
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 22 at 11:12 PM
$CGEN Share Price: $1.54 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.34 Potential Upside: 55% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
John_McClane911
John_McClane911 Dec. 19 at 9:40 PM
0 · Reply
TwitteringTom
TwitteringTom Dec. 18 at 7:33 PM
$CGEN Man this stock STINNKSSSSSSSSSSSSS.... 100 million royalties and nothing.... guess it makes sense people by doge and fart coin and companies with actual revenue and products do nothing
1 · Reply
TheRealDiamondJim
TheRealDiamondJim Dec. 18 at 1:58 PM
0 · Reply
TheInimitableInvestor
TheInimitableInvestor Dec. 17 at 11:59 PM
$CGEN I’ve been in and out of this name for many many years now, since the Martin Gerstel days. This has never been really high risk, but the issue is that no one knows or folllows the company and they have a very small investor base. With the news today the risk is lower than ever, I definitely see upside here and will be looking to re establish a position. It could be another few years before the stock does much of anything, but at least we know the have another 3 + years of cash.
0 · Reply
Latest News on CGEN
Compugen Ltd. (CGEN) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 10:51 AM EST - 6 weeks ago

Compugen Ltd. (CGEN) Q3 2025 Earnings Call Transcript


Compugen Reports Third Quarter 2025 Results

Nov 10, 2025, 7:00 AM EST - 6 weeks ago

Compugen Reports Third Quarter 2025 Results


Compugen to Participate in Stifel 2025 Healthcare Conference

Nov 4, 2025, 7:00 AM EST - 7 weeks ago

Compugen to Participate in Stifel 2025 Healthcare Conference


Compugen to Present at SITC 2025

Oct 6, 2025, 7:00 AM EDT - 2 months ago

Compugen to Present at SITC 2025


Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 6:30 AM EDT - 5 months ago

Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript


Compugen Reports Second Quarter 2025 Results

Aug 6, 2025, 7:00 AM EDT - 5 months ago

Compugen Reports Second Quarter 2025 Results


Compugen Ltd. (CGEN) Q1 2025 Earnings Call Transcript

May 19, 2025, 10:21 AM EDT - 7 months ago

Compugen Ltd. (CGEN) Q1 2025 Earnings Call Transcript


Compugen Reports First Quarter 2025 Results

May 19, 2025, 7:00 AM EDT - 7 months ago

Compugen Reports First Quarter 2025 Results


Compugen Ltd. (CGEN) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 10:34 AM EST - 10 months ago

Compugen Ltd. (CGEN) Q4 2024 Earnings Call Transcript


Compugen Reports Fourth Quarter and Full Year 2024 Results

Mar 4, 2025, 7:00 AM EST - 10 months ago

Compugen Reports Fourth Quarter and Full Year 2024 Results


Compugen: Immuno-Oncology Innovator Poised For A Comeback

Feb 18, 2025, 6:11 AM EST - 11 months ago

Compugen: Immuno-Oncology Innovator Poised For A Comeback


Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 3:35 PM EST - 1 year ago

Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript


Compugen Reports Third Quarter 2024 Results

Nov 12, 2024, 7:00 AM EST - 1 year ago

Compugen Reports Third Quarter 2024 Results


Compugen to Participate in Stifel 2024 Healthcare Conference

Nov 11, 2024, 7:00 AM EST - 1 year ago

Compugen to Participate in Stifel 2024 Healthcare Conference


Compugen to Present New Clinical Data at SITC 2024

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Compugen to Present New Clinical Data at SITC 2024


Compugen to Present at Single Cell Genomics 2024 Conference

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Compugen to Present at Single Cell Genomics 2024 Conference


Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 5:54 AM EDT - 1 year ago

Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript


Compugen Reports Second Quarter 2024 Results

Aug 6, 2024, 7:00 AM EDT - 1 year ago

Compugen Reports Second Quarter 2024 Results


Compugen to Present at Upcoming Antibody Industrial Symposium

Jun 17, 2024, 7:00 AM EDT - 1 year ago

Compugen to Present at Upcoming Antibody Industrial Symposium


Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript

May 20, 2024, 12:22 PM EDT - 1 year ago

Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript


Compugen Reports First Quarter 2024 Results

May 20, 2024, 7:00 AM EDT - 1 year ago

Compugen Reports First Quarter 2024 Results


Compugen Appoints David Silberman as Chief Financial Officer

May 15, 2024, 7:00 AM EDT - 1 year ago

Compugen Appoints David Silberman as Chief Financial Officer


mary46
mary46 Dec. 27 at 4:25 PM
$CGEN 3s feb
0 · Reply
BiPartisanB
BiPartisanB Dec. 25 at 1:38 PM
$CGEN Capital stewardship is becoming the defining attribute for how this story is priced. Execution reliability across quarters will determine whether confidence can compound. Credibility will build only through repeated confirmation across multiple cycles. Future re‑rating depends on tightening the gap between narrative and reality.
0 · Reply
John_McClane911
John_McClane911 Dec. 24 at 9:40 PM
$CGEN https://www.youtube.com/watch?v=t9WWj19YejM&list=RDt9WWj19YejM&start_radio=1
0 · Reply
John_McClane911
John_McClane911 Dec. 24 at 9:34 PM
$CGEN Chanukka Sameach
0 · Reply
John_McClane911
John_McClane911 Dec. 23 at 6:53 AM
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 22 at 11:12 PM
$CGEN Share Price: $1.54 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.34 Potential Upside: 55% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
John_McClane911
John_McClane911 Dec. 19 at 9:40 PM
0 · Reply
TwitteringTom
TwitteringTom Dec. 18 at 7:33 PM
$CGEN Man this stock STINNKSSSSSSSSSSSSS.... 100 million royalties and nothing.... guess it makes sense people by doge and fart coin and companies with actual revenue and products do nothing
1 · Reply
TheRealDiamondJim
TheRealDiamondJim Dec. 18 at 1:58 PM
0 · Reply
TheInimitableInvestor
TheInimitableInvestor Dec. 17 at 11:59 PM
$CGEN I’ve been in and out of this name for many many years now, since the Martin Gerstel days. This has never been really high risk, but the issue is that no one knows or folllows the company and they have a very small investor base. With the news today the risk is lower than ever, I definitely see upside here and will be looking to re establish a position. It could be another few years before the stock does much of anything, but at least we know the have another 3 + years of cash.
0 · Reply
Victory777777
Victory777777 Dec. 17 at 10:00 PM
$MGRT come on $CGEN Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
0 · Reply
John_McClane911
John_McClane911 Dec. 17 at 7:08 PM
0 · Reply
DirkInvest
DirkInvest Dec. 17 at 6:48 PM
$CGEN If a minority of the royalties are worth $90 mil for AZ, the majority royalties remaining should be worth over $100 million too. I do wonder what CGEN will do with all the money. Their cashhburn is quite small. I believe they have debts and already had quite some cash left. A cash runway into 2029, atleast there won't be any dilution.
1 · Reply
DirkInvest
DirkInvest Dec. 17 at 6:41 PM
$CGEN Did not expect I could buy for $1.50 after this news. No debt, low cashburn, probably more cash now then market cap and quite some future potential. Obviously undervalued, but too unknown to jump on any news. Its going to take a couple years before it gets major royalties, if the trials succeed that is. Could take some time, but a single large investor/fund would already be enough to shoot the share price into the sky.
0 · Reply
Victory777777
Victory777777 Dec. 17 at 5:53 PM
0 · Reply
John_McClane911
John_McClane911 Dec. 17 at 4:48 PM
0 · Reply
TwitteringTom
TwitteringTom Dec. 17 at 4:06 PM
$CGEN pure comedy
0 · Reply
Victory777777
Victory777777 Dec. 17 at 3:16 PM
$CGEN Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million $5
0 · Reply
einada
einada Dec. 17 at 2:58 PM
$CGEN lol! Back to previous close, what a pos!!!
0 · Reply
TwitteringTom
TwitteringTom Dec. 17 at 2:47 PM
$CGEN Pre market was an absolute MIRAGE lol
0 · Reply
TwitteringTom
TwitteringTom Dec. 17 at 2:44 PM
$CGEN Lol silly me for a moment i thought we might get some movement higher
0 · Reply
einada
einada Dec. 17 at 2:43 PM
$CGEN good news does nothing for this stock…
0 · Reply